People · Operator
Named in public records as an officer, director or promoter · active 2013–2021 · Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biostage, Inc. | — | Biotechnology | Series A | $36.5M | $1.8M | 2018 |
| Qview Medical, Inc. | — | Healthtech | Series A | $6.8M | $45.1M | 2013 |
| Ribogenics, Inc. | — | Biotechnology | Series A | $6.0M | $162.1M | 2021 |
Wei Zhang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Wei Zhang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Green | 1 | 8 |
| John Kennedy | 1 | 6 |
| Shih-Ping (Bob) Wang | 1 | 4 |
| Thomas Robinson | 1 | 3 |
| Ting Li | 1 | 3 |
| Jing Chen | 1 | 3 |
| Thomas McNaughton | 1 | 2 |
| Blaine McKee | 1 | 2 |
| Ronald Packard | 1 | 2 |
| Hong Yu | 1 | 1 |
| Mao Zhang | 1 | 1 |
| Joseph Damasio | 1 | 1 |
| Herman Sanchez | 1 | 1 |
| James Shmerling | 1 | 1 |
| Shunfu Hu | 1 | 1 |
| Jeffrey Young | 1 | 1 |
| Matthew Dallas | 1 | 1 |
| Peter Chakoutis | 1 | 1 |
| Yves Ribeill | 1 | 1 |
| Laurent Arthaud | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.